No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People’s Republic of China. The company offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. It is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. The company was founded in 2010 and is headquartered in Guangzhou, the People’s Republic of China.
www.gstzy.cnNo one on the platform currently holds 2273.HK.
No tracked institution reports a position in 2273.HK as of their last filing.
No one on the platform has traded 2273.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 18.2% | — | — | — | ||
| Rev. Growth % | 7.5% | 28.6% | ||||
| Profit Margin % | 10.9% | 1.2% | ||||
| Free Cash Flow Margin % | 14.9% | 13.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.9B | +19.4% | $1.95 | $1.79–$2.14 | — | 10 |
| 2027 | $4.5B | +15.3% | $2.20 | $1.82–$2.52 | — | 13 |
| 2028 | $5.2B | +14.5% | $2.58 | $2.17–$2.82 | — | 12 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-28 | $0.92 | $0.80 | -13.8% |
| 2026-03-31 | $1.05 | $1.09 | +3.8% |
| 2025-08-29 | $0.76 | $0.68 | -10.2% |
| 2024-12-31 | $1.18 | $0.84 | -28.9% |
| 2024-06-30 | $0.66 | $0.46 | -29.5% |
| 2024-06-18 | $0.92 | $0.73 | -21.3% |
| 2023-06-30 | $0.42 | $0.41 | -3.0% |
| 2022-12-31 | $0.67 | $0.60 | -9.6% |
| $2.09 |
| -1.18% |
| $5.6B |
| — |
| 2172.HKMicroPort NeuroTech Limited | $8.05 | +0.00% | $4.7B | — |
| 2373.HKBeauty Farm Medical and Health Industry Inc. | $18.09 | -1.63% | $4.5B | — |
Source: Financial Modeling Prep · peers by sector/industry